Not raking in the bucks as expected at this point. Amazing that we have 5MIL in cash considering we expanded so much in the last year. Acquired Geron assets as well as LifeMap, hired new employees, etc.
I do believe BTX is at a major turning point as a company, making a transition from an R&D to therapeutics company. Most pieces are in place, but money is the question at this point in terms of funding clinical trials.
Dr. West is just as good a business man as he is scientist so i have no doubt he will sure up funding.
I would think Dr. West would announce a partnership soon to get the stock back in the $4-6 range, or at least a strong indication os success in pre-clinical studies.
On the therapeutics front:
-Weill Cornell Medical and OncoCyte announced a commencement on anti-tumor animal/preclinical studies.
-Arnold Caplan CEO of OrthoCyte will be speaking in numerous places in the next few months(April22, June 23, and August 19), which may indicate announcement concerning OrthoCytes cartilage regen progress.
Over all i think investors spot a buying opportunity right now before the 'gettin gets good' this year. To end i would just say now might not be a good time to bet against West. Again, he is a great biz man and very aggressive when his back is against the wall. So i would not be surprised if he counteracted 4Q results with some ground breaking news in the short term.
For how much? They cost $35 each to create. They have no function whatsoever except to create tax dodges for ak/neal/garfies/mikey.
No therapeutic or scientific worth whatsoever.
Wanna find out for yourself? Go to the CA sec of state and look for "register a corporationonline" or whatever its called.